Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Small Cell Lung Carcinoma 1Sarcoma 1Retinoblastoma 1Prostatic Neoplasms 1Platinum-Refractory Fallopian Tube Carcinoma 1Neuroblastoma 1Neoplasm Metastasis 1Lymphoma 1Lung Neoplasms 1Glioma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Advanced Solid Tumors 1

Interventions

nirogacestat 1navoximod 1ixabepilone 1atezolizumab 1Topotecan 1Radiosurgery 1Pemetrexed 1Lapatinib 1Hydroxyurea 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Advanced Solid Tumors × Topotecan × Clear all
NCT00682279 2015-04-17

A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors

GlaxoSmithKline

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡